V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009641 | 260006190 | 1.62 | null | Curative (C) | 2014-10-15 | 2014-10-15 | EP | N | N | 260007556 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009642 | 260006190 | 1.83 | 92.4 | Palliative (P) | 2016-08-24 | 2016-08-27 | ETOPOSIDE | 2 | N | 260007556 | NOT MATCHED |
| 260009643 | 260006190 | null | 69.1 | Adjuvant (A) | 2014-05-25 | 2014-06-01 | EP | N | N | 260007556 | EP |
| 260009644 | 260017463 | 1.82 | 78 | null | 2018-02-14 | 2018-02-14 | Cisplatin + Etoposide (3 day) | 02 | null | 260007601 | CISPLATIN + IFOSFAMIDE + VINBLASTINE |
| 260009645 | 260006191 | 1.68 | 90.1 | Disease modification (D) | 2017-01-29 | 2017-02-13 | Carboplatin + Vinorelbine IV | 02 | N | 260007638 | RITUXIMAB |
| 260009646 | 260006191 | 1.53 | 69.7 | Curative (C) | 2018-08-04 | 2018-08-07 | Hydroxycarbamide | N | N | 260007638 | CARBOPLATIN + PACLITAXEL |
| 260009647 | 260006191 | 1.73 | 90.4 | Curative (C) | null | 2018-09-06 | Cisplatin + Etoposide (3 day) | null | null | 260007638 | CEB |
| 260009648 | 260017464 | 1.7 | 50.3 | Palliative (P) | 2016-08-30 | 2016-09-15 | FCR | N | N | 260007672 | RITUXIMAB |
| 260009649 | 260017464 | 1.79 | 85.5 | null | 2018-05-13 | 2018-05-13 | STS Rhabdomyosarcoma RMS 2005 VAVV | 2 | N | 260007672 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009650 | 260017464 | 1.7 | null | Neo-adjuvant (N) | 2017-06-17 | 2017-06-17 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 260007672 | CISPLATIN + ETOPOSIDE |
| 260009651 | 260006192 | 1.8 | null | Palliative (P) | 2013-10-23 | 2013-11-22 | 111 Trial (formerly BEP 111) | null | N | 260007708 | CISPLATIN + ETOPOSIDE |
| 260009652 | 260012328 | 1.81 | 101.6 | Disease modification (D) | 2017-06-22 | 2017-07-04 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260007709 | CISPLATIN + ETOPOSIDE |
| 260009653 | 260015678 | 1.74 | 85.7 | Curative (C) | 2017-12-20 | 2017-12-20 | TIP | 2 | N | 260007740 | TIP |
| 260009654 | 260006193 | 1.76 | null | Curative (C) | 2018-05-31 | 2018-06-08 | GC Int Guide Excranial GermCell JEB | N | N | 260007750 | CISPLATIN + ETOPOSIDE |
| 260009655 | 260012329 | null | 77 | null | 2016-03-10 | 2016-03-10 | CISPLATIN + ETOPOSIDE | N | N | 260007751 | ETOPOSIDE |
| 260009656 | 260006194 | 1.78 | null | Neo-adjuvant (N) | 2017-04-02 | 2017-05-21 | Carboplatin + Etoposide IV 3 day | 02 | N | 260007760 | GEMCITABINE + OXALIPLATIN |
| 260009657 | 260006194 | 1.62 | 114.6 | Curative (C) | 2018-09-08 | 2018-09-10 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | null | 260007760 | EP |
| 260009658 | 260006195 | 1.73 | 135 | Palliative (P) | 2019-02-28 | 2019-03-22 | Trial Unspecified | 02 | N | 260007799 | TIP |
| 260009659 | 260006195 | 1.77 | 63 | Curative (C) | 2016-02-12 | 2016-02-17 | Cisplatin + Etoposide (5 day) | N | N | 260007799 | CARBOPLATIN + ETOPOSIDE |
| 260009660 | 260006196 | 1.7 | null | Palliative (P) | 2014-10-12 | 2014-10-24 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | N | 260007812 | CARBOPLATIN + ETOPOSIDE |
| 260009661 | 260006196 | 1.75 | 93.6 | Curative (C) | 2017-01-18 | 2017-02-16 | Carboplatin + Etoposide IV 3 day | 2 | N | 260007812 | ACE (GERM CELL) |
| 260009662 | 260006196 | 1.79 | 69.5 | Not known (9) | 2016-06-15 | 2016-06-18 | Bendamustine +/- Prednisolone | N | null | 260007812 | CISPLATIN + ETOPOSIDE |
| 260009663 | 260006197 | 0 | null | Disease modification (D) | 2014-02-06 | 2014-02-15 | CARBOPLATIN + VINORELBINE | N | N | 260007854 | CISPLATIN + ETOPOSIDE |
| 260009664 | 260006197 | 1.56 | null | null | 2018-04-15 | 2018-05-01 | Rituximab | N | N | 260007854 | RITUXIMAB |
| 260009665 | 260006198 | 1.66 | null | Curative (C) | 2018-02-10 | 2018-02-24 | CARBOPLATIN + GEMCITABINE | N | N | 260007889 | RITUXIMAB |
| 260009666 | 260012334 | null | 85.5 | Palliative (P) | 2014-05-02 | 2014-05-05 | TIP | 02 | N | 260007890 | CARBOPLATIN + PEMETREXED |
| 260009667 | 260012334 | 1.8 | 76 | Palliative (P) | 2013-11-18 | 2013-11-24 | Cisplatin + Etoposide (3 day) | N | N | 260007890 | CARBOPLATIN + ETOPOSIDE |
| 260009668 | 260012334 | 1.57 | 65.6 | Palliative (P) | 2017-11-06 | 2017-11-07 | Rituximab (Maintenance) | N | N | 260007890 | RITUXIMAB |
| 260009669 | 260006199 | 1.78 | 50 | Curative (C) | 2016-07-10 | 2016-07-31 | Rituximab | N | N | 260007917 | RITUXIMAB |
| 260009670 | 260006199 | 1.68 | 77 | Curative (C) | 2013-11-09 | 2013-11-21 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260007917 | TIP |
| 260009671 | 260006200 | null | 78.4 | null | 2017-09-24 | 2017-09-24 | EC | 02 | null | 260007966 | RITUXIMAB |
| 260009672 | 260006200 | 1.73 | 76.8 | Disease modification (D) | 2014-02-02 | 2014-02-13 | Trial Unspecified | N | N | 260007966 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009673 | 260015681 | 1.78 | null | Curative (C) | 2017-05-22 | 2017-05-22 | Cisplatin + Etoposide (3 day) | N | N | 260007997 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009674 | 260006201 | 0 | 62.5 | Palliative (P) | 2018-08-01 | 2018-08-13 | Paclitaxel (2 or 3 weekly) | 02 | N | 260008017 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009675 | 260006202 | 1.83 | null | Curative (C) | 2017-12-08 | 2017-12-10 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260008025 | CISPLATIN + ETOPOSIDE |
| 260009676 | 260006202 | 1.56 | 70.3 | null | 2015-11-08 | 2015-11-08 | Rituximab | 02 | N | 260008025 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260009677 | 260006203 | 0.82 | null | Curative (C) | 2017-06-30 | 2017-07-08 | ETOPOSIDE | 02 | N | 260008101 | NOT MATCHED |
| 260009678 | 260006203 | 1.55 | 75.6 | Palliative (P) | null | 2018-07-14 | FEC 100 | N | N | 260008101 | FCR |
| 260009679 | 260006204 | 1.76 | null | Palliative (P) | 2016-01-26 | 2016-01-27 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260008107 | CISPLATIN + ETOPOSIDE |
| 260009680 | 260006204 | 1.78 | 91.5 | Curative (C) | 2015-04-23 | 2015-04-26 | EP | 02 | N | 260008107 | CARBOPLATIN + ETOPOSIDE |
| 260009681 | 260006205 | 1.69 | 90.96 | Curative (C) | 2016-07-31 | 2016-08-30 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | 2 | 260008128 | CISPLATIN + ETOPOSIDE |
| 260009682 | 260012340 | 1.65 | 91.5 | Curative (C) | 2016-09-09 | 2016-09-09 | Rituximab (Maintenance) | N | N | 260008173 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 260009683 | 260006206 | 1.69 | 112.1 | Disease modification (D) | 2014-09-26 | 2014-10-02 | EP | N | N | 260008176 | CARBOPLATIN + ETOPOSIDE |
| 260009684 | 260006206 | 1.68 | 77.4 | null | 2017-02-02 | 2017-02-23 | Bendamustine +/- Prednisolone | 02 | N | 260008176 | DA |
| 260009685 | 260006207 | 1.76 | 90.7 | null | 2018-05-10 | 2018-05-12 | 111 Trial (formerly BEP 111) | N | N | 260008239 | CISPLATIN + ETOPOSIDE |
| 260009686 | 260012342 | 1.74 | 96.6 | Adjuvant (A) | null | 2018-05-25 | Rituximab | null | null | 260008244 | CARBOPLATIN + PEMETREXED |
| 260009687 | 260012342 | null | null | Adjuvant (A) | 2017-09-01 | 2017-09-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260008244 | RITUXIMAB |
| 260009688 | 260012342 | null | 73 | Palliative (P) | null | 2016-11-05 | Cisplatin + Etoposide (5 day) | N | null | 260008244 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009689 | 260012342 | 1.65 | 60 | null | 2017-09-13 | 2017-09-24 | Cisplatin + Etoposide (5 day) | 2 | null | 260008244 | CISPLATIN + ETOPOSIDE |
| 260009690 | 260006208 | 1.76 | 73.2 | Palliative (P) | 2017-03-15 | 2017-03-19 | CARBOPLATIN + ETOPOSIDE | N | N | 260008307 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |